.png)
.png)
Total amount raised
Latest funding date
Location
Chris Gibson is the Co-Founder and CEO of Recursion, a company at the forefront of using advanced technologies like machine learning and AI to revolutionize drug discovery. Under his leadership, Recursion has grown significantly, becoming a leader in the TechBio sector.
Who is the CEO of Recursion?
Chris Gibson's journey to becoming the CEO of Recursion is marked by a blend of academic rigor and entrepreneurial spirit. His vision was to leverage advanced technologies like machine learning and AI to revolutionize drug discovery. Under his leadership, Recursion has grown into a publicly traded company, known for its innovative approach and significant contributions to the biopharma industry.
Gibson's commitment to interdisciplinary collaboration and support for diverse founders further underscores his impactful role in the life sciences community.
Work History
Chris Gibson's work history is marked by a series of significant roles in various organizations. Here is a list of the places he has worked previously:
- Recursion - Co-Founder and CEO (2013 to Present)
- Cure HHT - Member Board of Directors (2016 to 2020)
- University of Utah - MD/PhD Student (2009 to 2013)
- UTHSCSA - MD/PhD Student (2005 to 2009)
Education History
Chris Gibson's educational background is both extensive and diverse, reflecting his commitment to interdisciplinary learning. He began his academic journey at Rice University, where he earned a Bachelor of Science in Bioengineering and Biomedical Engineering, as well as a Bachelor of Arts in Managerial Studies, both completed in 2005. Gibson then pursued advanced studies at the University of Utah, obtaining a Ph.D. in Bioengineering between 2009 and 2013, and concurrently working towards a Doctor of Medicine (MD), which he completed in 2016. Additionally, he expanded his entrepreneurial skills by earning an IGNITE Certificate in Entrepreneurship/Entrepreneurial Studies from Stanford University Graduate School of Business in 2013. This diverse educational foundation has equipped Gibson with a unique blend of scientific expertise and business acumen, driving his innovative approach in the biopharma industry.
When did Chris Gibson join Recursion?
Chris Gibson co-founded Recursion on November 1, 2013, while he was pursuing his MD/PhD at the University of Utah. Since the company's inception, he has served as its CEO. This means that Gibson has been at the helm of Recursion for nearly a decade, guiding the company through its growth and development in the biopharma industry.
His leadership has been instrumental in leveraging advanced technologies like machine learning and AI to revolutionize drug discovery, making significant strides in the field.
